143 related articles for article (PubMed ID: 21288162)
21. Protein serine/threonine phosphatases: life, death, and sleeping.
Gallego M; Virshup DM
Curr Opin Cell Biol; 2005 Apr; 17(2):197-202. PubMed ID: 15780597
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
23. Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center.
Mondragon A; Griffith EC; Sun L; Xiong F; Armstrong C; Liu JO
Biochemistry; 1997 Apr; 36(16):4934-42. PubMed ID: 9125515
[TBL] [Abstract][Full Text] [Related]
24. Conversion of protein phosphatase 1 catalytic subunit to a Mn(2+)-dependent enzyme impairs its regulation by inhibitor 1.
Endo S; Connor JH; Forney B; Zhang L; Ingebritsen TS; Lee EY; Shenolikar S
Biochemistry; 1997 Jun; 36(23):6986-92. PubMed ID: 9188695
[TBL] [Abstract][Full Text] [Related]
25. The 3D structure of protein phosphatase 2A: new insights into a ubiquitous regulator of cell signaling.
Mumby M
ACS Chem Biol; 2007 Feb; 2(2):99-103. PubMed ID: 17313179
[TBL] [Abstract][Full Text] [Related]
26. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
27. Studies of small molecule interactions with protein phosphatases using biosensor technology.
Stenlund P; Frostell-Karlsson A; Karlsson OP
Anal Biochem; 2006 Jun; 353(2):217-25. PubMed ID: 16597430
[TBL] [Abstract][Full Text] [Related]
28. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.
Endo S; Zhou X; Connor J; Wang B; Shenolikar S
Biochemistry; 1996 Apr; 35(16):5220-8. PubMed ID: 8611507
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of the Ca(2+)/calmodulin-dependent protein kinase phosphatase family (CaMKP and CaMKP-N).
Sueyoshi N; Takao T; Nimura T; Sugiyama Y; Numano T; Shigeri Y; Taniguchi T; Kameshita I; Ishida A
Biochem Biophys Res Commun; 2007 Nov; 363(3):715-21. PubMed ID: 17897624
[TBL] [Abstract][Full Text] [Related]
30. The beta12-beta13 loop of protein phosphatase-1 is involved in activity regulation.
Xie X; Xue C; Huang W; Wei Q
IUBMB Life; 2006 Aug; 58(8):487-92. PubMed ID: 16916787
[TBL] [Abstract][Full Text] [Related]
31. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
Liu JY; Chen XE; Zhang YL
Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
[TBL] [Abstract][Full Text] [Related]
32. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.
Alessi DR; Smythe C; Keyse SM
Oncogene; 1993 Jul; 8(7):2015-20. PubMed ID: 8390041
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum serine/threonine phoshoprotein phosphatases (PPP): from housekeeper to the 'holy grail'.
Bajsa J; Duke SO; Tekwani BL
Curr Drug Targets; 2008 Nov; 9(11):997-1012. PubMed ID: 18991611
[TBL] [Abstract][Full Text] [Related]
34. Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates.
Brautigan DL; Shenolikar S
Annu Rev Biochem; 2018 Jun; 87():921-964. PubMed ID: 29925267
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins.
Sheppeck JE; Gauss CM; Chamberlin AR
Bioorg Med Chem; 1997 Sep; 5(9):1739-50. PubMed ID: 9354230
[TBL] [Abstract][Full Text] [Related]
36. Eukaryotic-like Phosphoprotein Phosphatase (PPP) enzyme evolution: interactions with environmental toxins and regulatory proteins.
Kerk D; White-Gloria C; Johnson JJ; Moorhead GB
Biosci Rep; 2023 May; 43(5):. PubMed ID: 37144562
[TBL] [Abstract][Full Text] [Related]
37. Recent progress on the structure of Ser/Thr protein phosphatases.
Wang B; Zhang P; Wei Q
Sci China C Life Sci; 2008 Jun; 51(6):487-94. PubMed ID: 18488168
[TBL] [Abstract][Full Text] [Related]
38. Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
Lajarín-Cuesta R; Arribas RL; De Los Ríos C
Expert Opin Ther Pat; 2016; 26(3):389-407. PubMed ID: 26853448
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
40. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?
Honkanen RE; Golden T
Curr Med Chem; 2002 Nov; 9(22):2055-75. PubMed ID: 12369870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
